Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 13

CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban

Total article views   HTML views PDF downloads Totals
6,152 Dovepress* 5,148+ 864 6,012
PubMed Central* 1,004 242 1,246
Totals 6,152 1,106 7,258
*Since 23 January 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar